Cover; Half-title; Series-title; Title; Copyright; Contents; Contributors; Editors; Other Contributors; Series Editors' Preface; Editors' Preface; Introduction: Access to essential medicines: public health and international law; 1. Prologue; 2. Connecting public and international law; 3. The international institutions; 4. Structure of the volume; 5. Conclusion; Part I International trade; 1 TRIPS and essential medicines: must one size fit all? Making the WTO responsive to the global health crisis; 2 The TRIPS Waiver as a recognition of public health concerns in the WTO
3 Public law challenges to the regulation of pharmaceutical patents in the US bilateral free trade agreements4 Global health and development: patents and public interest; Part II Innovation; 5 The Health Impact Fund: better pharmaceutical innovations at much lower prices; 6 The Health Impact Fund: a critique; 7 A prize system as a partial solution to the health crisis in the developing world; 8 Innovation and insufficient evidence: the case f
Summary
This book examines global health problems through the lens of public and international law, focusing on access to essential medicines
